RE:RE:RE:McMaster deal is bigwestcoast1000 is correct in the description of in-kind. It is non-cash and non-dilutive. The most important part of these projects is the training of skilled people. It is the doctoral and post-graduate students who can serve as the best conduits for technology transfer from the McMaster professors' labs.
It's also important to note that the McMaster research team won this grant under a stiff competition, where only 1 in 4 funding applicants is successful.
Congratulations is in order for both McMaster and Ceapro!
westcoast1000 wrote: In-kind support would likely include giving them access to the PDX technology, access to Ceapro findings about various materials after treatment, some Ceapro overhead, and some time by Ceapro research and professional staff. In other words, the in-kind expenses are ones that Ceapro would have borne in any case.
So it is a very large win and big increase in R and D capacity for Ceapro.